title: How Health Professionals Conceptualize and Represent Placebo Treatment in Clinical Trials and How Their Patients Understand It: Impact on Validity of Informed Consent.
abstract: Previous studies suggested that many patients, who have given their informed consent to participate in randomized controlled trials (RCT), have somewhat limited understanding of what a placebo treatment is. We hypothesized that the relationship between patients and their health professionals plays a central role in this understanding.
  
  
  
  We interviewed 12 patients included in RCTs (nine suffering from Parkinson's disease and three from Huntington's disease) and 18 health professionals involved with RCTs (eight principal investigators, four associated physicians and six clinical research associates). Semi-structured interviews were conducted after the RCTs had ended but before the treatment allocation was revealed.
  
  
  
  Only two patients clearly understood the aim of placebo-controlled RCTs. Only one principal investigator said she asks all her patients whether they agree to participate in RCTs. The seven others said they only ask patients who seem more likely to be compliant. Their selection criteria included docility and personality traits associated in other studies with enhanced placebo responses. According to 13 of the 18 health professionals, their relationship with patients may influence the amplitude of the placebo response. All but one clinical research associates added that the placebo response could result from a "maternal" type of care. All principal investigators said they have a strong influence on their patient's decision to participate. Finally, when interviewees were asked to narrate a memory of a medically unexplained healing, in eight of 11 physicians' narratives the beneficiary was a child while in 10 of 12 patients' narratives it was an adult.
  
  
  
  Our observations suggest that the interrelationship between health professionals and patients involved in RCTs could be compared to that between parents and children. Therefore, adherence to formal rules regarding informed consent does not ensure a balanced relationship between patients and health professionals.
authors.affiliation: Department of Psychology, University of Poitiers, 86000, Poitiers, France.
authors.forename: Pascal-Henri
authors.initials: PH
authors.lastname: Keller
authors.affiliation: Department of Psychology, University of Bordeaux, 33076 Bordeaux, France.
authors.forename: Olivier
authors.initials: O
authors.lastname: Grondin
authors.affiliation: Institute of Neurodegenerative Diseases, University of Bordeaux, 33076 Bordeaux, France.|Centre National de la Recherche Scientifique, CNRS UMR5293, 33076 Bordeaux, France.
authors.forename: François
authors.initials: F
authors.lastname: Tison
authors.affiliation: Institute of Neurodegenerative Diseases, University of Bordeaux, 33076 Bordeaux, France.|Centre National de la Recherche Scientifique, CNRS UMR5293, 33076 Bordeaux, France.
authors.forename: Francois
authors.initials: F
authors.lastname: Gonon
mesh_terms: D007722:Health Knowledge, Attitudes, Practice; D006282:Health Personnel / Q000523:psychology / Q000592:standards; D006801:Humans; D006816:Huntington Disease / Q000188:drug therapy; D007258:Informed Consent / Q000523:psychology / Q000592:standards*; D010300:Parkinson Disease / Q000188:drug therapy; D010361:Patients / Q000523:psychology; D010817:Physician-Patient Relations; D010919:Placebos; D016032:Randomized Controlled Trials as Topic / Q000523:psychology / Q000592:standards*
chemical_list: D010919:Placebos